Jean-Sebastien Garrigue

WORK HISTORY

EDUCATION

SKILLS

ABOUT JEAN-SEBASTIEN GARRIGUE

My 25+ years in the global healthcare sector have cultivated a robust and diverse skill set in drug development strategy, corporate leadership, and international market expansion. I possess proven expertise in establishing and scaling global R&D organizations, spearheading digital transformation initiatives, and fostering patient-centric development models. My experience spans the full spectrum of product lifecycle management, from early-stage innovation and intellectual property development to successful market access and commercialization across multiple regions. I excel in cross-functional team leadership, strategic decision-making, and navigating complex regulatory and financial ecosystems, consistently delivering results and creating long-term value.My work has consistently bridged science, business, and leadership, delivering results at the intersection of patient needs, regulatory rigor, and shareholder value. I have successfully: Secured €70M+ in Series B&C funding and led a successful IPO (Novagali Pharma) Brought numerous medicinal products, medical devices, and OTC drugs to market across the EU, US, China, Japan and Asia Built and scaled global teams, fostering high performance and innovation in EMEA, Japan, and globally Established Global R&D Organization, Digital Transformation, Patient Centricity and Medical Device Expertise Center Served in strategic executive roles over the past 15 years, spanning R&D site leadership, Development head, business development, chief of staff, and board advisory capacitiesMy leadership style combines multiplier thinking, servant leadership, and a global lens, enabling organizations to navigate complex ecosystems and drive strategic growth. I am passionate about mentoring future leaders, cultivating resilient cultures, and aligning innovation with business outcomes.I currently advise leadership teams on drug development strategy, cross-border growth, and organizational and operational transformation.Always open to connecting with visionary leaders, investors, and innovators shaping the future of healthcare.